Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Blood|December 1, 1995
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationS Giralt, J Hester, Y Huh, et al.
Eclinicalmedicine|July 26, 2021
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trialSusan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 21, 2023
Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancyS E Carlson, B J Gajewski, C J Valentine, et al.
Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.
American Journal of Hematology|July 10, 2001
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaS Bibawi, D Abi-Said, L Fayad, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2019
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot StudyCarol J Fabian, Lauren Nye, Kandy R Powers, et al.
Bone Marrow Transplantation|October 12, 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationD Przepiorka, I Khouri, C Ippoliti, et al.
Bone Marrow Transplantation|November 1, 1996
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donorsM Körbling, K W Chan, P Anderlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphomaD Przepiorka, K van Besien, I Khouri, et al.
Blood|June 15, 1997
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapyS Giralt, E Estey, M Albitar, et al.
Pageof 25